StonvexLoading…
StonvexStonvexStonvexCore line items from HCSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $462.77M | $1.84B | $1.37B | $906.15M |
Operating Income | $34.54M | $67.87M | $39.31M | $-17.99M |
Net Income | $26.06M | $59.06M | $27.82M | $-32.37M |
EPS (Diluted) | $0.37 | $0.81 | $0.38 | $-0.21 |
Total Assets | $814.85M | $794.25M | $804.30M | $802.20M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $136.17M | $125.19M | $124.39M | $82.82M |
Free Cash Flow OCF − CapEx | $42.33M | $139.15M | $123.14M | $53.19M |
Shares Outstanding | 68.93M | 69.60M | 70.67M | 72.41M |